ALID

Allied Corp. [ALID] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

ALID Stock Summary

Top 10 Correlated Stocks

ALID


In the News

08:55 29 Mar 2024 ALID

Allied Corp Announces Signing of Supply Contracts of 85,000, 40,000 and 24,000 Kilograms for the 2022 Calendar Year

KELOWNA, British Columbia, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Allied Corp . ("Allied" or the “Company”) (OTCQB: ALID) is pleased to announce the signing of supply contracts for the 2022 calendar. Allied will be only providing cannabis flower after the Colombian government allows it and will provide supply only to countries where it is legal to sell into (for example, the United States only allows for THC levels to be less than 0.3%).

08:55 29 Mar 2024 ALID

Allied Corp Announces Approval of Research and Plant Breeding License for Psychoactive and Non-Psychoactive Cannabis in Colombia

KELOWNA, British Columbia, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Allied Corp . ("Allied" or the “Company”) (OTCQB: ALID) is pleased to announce that is has been granted additional licensing that enables the Company to function as a research and plant breeding unit for psychoactive and non-psychoactive Cannabis in Colombia.

05:55 29 Mar 2024 ALID

Allied Corp Provides Results of Recent Third Party Audit Confirming Production Costs and Optimization of Production

KELOWNA, British Columbia, Sept. 24, 2021 (GLOBE NEWSWIRE) -- Allied Corp . ("Allied" or the “Company”) (OTCQB: ALID) is pleased to announce the results of a third party audit that was conducted at the Allied Colombian Campus. The focus of the audit was Allied's cost of production, inventory control and optimization of its production approach.

05:55 29 Mar 2024 ALID

Allied Corp. Announces Approval of Second CBD Isolate Import Permit for Australia and Submits Application for the Import of Dried Cannabis

KELOWNA, British Columbia., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Allied Corp . ("Allied" or the “Company”) (OTCQB: ALID) is pleased to announce that it has received approval of a second import permit for export of CBD isolate produced at Allied's Colombian campus that is destined for the Australian market.

08:55 29 Mar 2024 ALID

Allied Corp Provides Update Regarding Nevada Building and Option to Purchase Nevada State License

KELOWNA, British Columbia, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Allied Corp . ("Allied" or the “Company”) (OTCQB: ALID) is pleased to announce that it has completed the construction of its 8900 square foot modular building that is currently situated in the City of North Las Vegas. In addition to this, the City of North Las Vegas has now approved the land use for the intended location of the building. This building is awaiting the Nevada State engineering approvals in order to proceed with the building permit and then go to tender for trades to be able to complete the foundation upon which the building will be placed.

08:55 29 Mar 2024 ALID

Allied Corp. Advances Psilocybin Product Psilonex™ RX and Initiates Manufacturing Process

KELOWNA, British Columbia, Sept. 10, 2021 (GLOBE NEWSWIRE) -- Allied Corp . ("Allied" or the “Company”) (OTCQB: ALID) is pleased to announce that it has initiated the manufacturing activities for Psilonex™ RX – Allied's proprietary psilocybin product. On June 29, 2021, Allied announced its manufacturing agreement with HAVN Life Sciences to manufacture Psilonex™ RX under their legal licenses and manufacturing process.

08:55 29 Mar 2024 ALID

Allied Corp. Initiates Additional Shipment of 200kgs of CBD Distillate From Colombia to Nevada, United States

KELOWNA, British Columbia, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Allied Corp . ("Allied" or the “Company”) (OTCQB: ALID) is pleased to announce that it has received approval from the Colombian Ministry of Justice to initiate a shipment of 200kgs of extracted CBD distillate product (containing less than 0.3% THC) to the United States. This shipment is specifically destined for the State of Nevada, which includes Las Vegas and Reno, and represents Allied's largest shipment of CBD distillate product (containing less than 0.3% THC) to date.

08:55 29 Mar 2024 ALID

Allied Corp. Signs Additional Supply Contracts for the Export of Cannabis Flower and CBD Isolate From Colombia to Australia

KELOWNA, British Columbia, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Allied Corp . ("Allied" or the “Company”) (OTCQB: ALID) is pleased to announce that it has secured two agreements with one of the Australian medicinal cannabis companies that has received Major Project Status from the Australian Department of Industry, Science and Technology. Allied has signed two binding agreements with this company to supply initially 5 kilograms of CBD isolate, as well as a second agreement to supply 5 kilograms of cannabis flower, both of which we believe are moving towards monthly contracts with increased volumes. This agreement to supply cannabis flower is the first of its kind that Allied has signed following the announcement by the Colombian Government regarding the approval to export Colombian produced cannabis flower.

08:55 29 Mar 2024 ALID

Allied Corp Initiates Additional Commercial CBD Shipment From Colombia Destined for Colorado, United States

KELOWNA, British Columbia, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) an international medical company focused on creating and providing health solutions to address today's medical mental health issues is pleased to announce that it has initiated its second commercial shipment of cannabidiol (“CBD”) (containing less than 0.3% THC) from Colombia into the United States, specifically to the State of Colorado.

08:55 29 Mar 2024 ALID

Allied Corp Completes Commercial CBD Shipments From Colombia Into Australia

KELOWNA, British Columbia, July 29, 2021 (GLOBE NEWSWIRE) -- Allied Corp . ("Allied" or the “Company”) (OTCQB: ALID) an international medical company focused on creating and providing health solutions to address today's medical mental health issues is pleased to announce that it has completed its commercial shipments of cannabidiol (“CBD”) isolate from Colombia to Australia. This purchase agreement is intended to continue with a monthly supply contract.

ALID Financial details

Company Rating
Sell
Market Cap
6.62M
Income
-10.88M
Revenue
72.1K
Book val./share
-0.07
Cash/share
0
Dividend
-
Dividend %
-
Employees
150
Optionable
No
Shortable
Yes
Earnings
16 Dec 2020
P/E
-0.84
Forward P/E
-
PEG
0.22
P/S
132.46
P/B
-1.32
P/C
-
P/FCF
-4.67
Quick Ratio
0.04
Current Ratio
0.05
Debt / Equity
-0.85
LT Debt / Equity
-0.01
-
-
EPS (TTM)
-0.11
EPS next Y
-
EPS next Q
1.34
EPS this Y
-38.89%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
138.12%
-
-
-
-
SMA20
75%
SMA50
-22.22%
SMA100
-53.33%
Inst Own
0%
Inst Trans
-0.37%
ROA
-527%
ROE
339%
ROC
1.11%
Gross Margin
-2028%
Oper. Margin
-10491%
Profit Margin
-15088%
Payout
-
Shs Outstand
101.84M
Shs Float
66.09M
-
-
-
-
Target Price
-
52W Range
0.0211-0.31713
52W High
-
52W Low
-
RSI
52.89
Rel Volume
0.48
Avg Volume
16.38K
Volume
7.85K
Perf Week
-15.03%
Perf Month
3.17%
Perf Quarter
-60.37%
Perf Half Y
-67.5%
-
-
-
-
Beta
-0.182
-
-
Volatility
0%, 0.01%
Prev Close
0%
Price
0.065
Change
-15.03%

ALID Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-08-31

Metric History 2019-03-312020-08-312021-08-312022-08-31 2023-08-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
0-0.08-0.15-0.18-0.11
Operating cash flow per share
0-0.04-0.05-0.05-0.02
Free cash flow per share
0-0.04-0.05-0.06-0.02
Cash per share
000.0100
Book value per share
00.05-0.01-0.01-0.07
Tangible book value per share
00.01-0.01-0.02-0.07
Share holders equity per share
00.05-0.01-0.01-0.07
Interest debt per share
00.030.050.070.07
Market cap
108.32M125.16M86.02M42.37M22.75M
Enterprise value
108.32M127.07M89.33M47.35M28.4M
P/E ratio
-4.69K-18.51-7.07-2.53-2.13
Price to sales ratio
006.87K255.83315.52
POCF ratio
-8.57K-39.6-21.74-9.89-11.62
PFCF ratio
-8.57K-38.25-20.58-7.72-11.13
P/B Ratio
-1.81K33.79-88.61-33.04-3.3
PTB ratio
-1.81K33.79-88.61-33.04-3.3
EV to sales
007.14K285.93393.91
Enterprise value over EBITDA
-4.69K-41.79-12.67-3.33-4.24
EV to operating cash flow
-8.57K-40.2-22.58-11.05-14.51
EV to free cash flow
-8.57K-38.83-21.37-8.63-13.89
Earnings yield
0-0.05-0.14-0.4-0.47
Free cash flow yield
0-0.03-0.05-0.13-0.09
Debt to equity
00.54-3.85-3.96-0.85
Debt to assets
00.280.810.882.84
Net debt to EBITDA
0-0.63-0.47-0.35-0.84
Current ratio
00.060.170.180.05
Interest coverage
0-23.66-12.15-11.59-11.89
Income quality
0.550.480.340.280.18
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00464.0986.0272.4
Research and developement to revenue
0000.070
Intangibles to total assets
00.460.040.030.02
Capex to operating cash flow
00.040.060.280.04
Capex to revenue
00-17.88-7.28-1.22
Capex to depreciation
0-0.24-0.41-14.59-0.64
Stock based compensation to revenue
00212.9844.242.27
Graham number
00.290.20.240.42
ROIC
0.39-0.59-2.67-3.8712.14
Return on tangible assets
-224.35-1.78-2.74-3-5.28
Graham Net
0-0.04-0.06-0.07-0.09
Working capital
-59.8K-2.87M-4.47M-5.67M-8.38M
Tangible asset value
-59.8K404.16K-1.17M-1.48M-6.92M
Net current asset value
-59.8K-3.2M-4.69M-5.83M-8.48M
Invested capital
00.54-3.85-3.96-0.85
Average receivables
0041.42K102.13K127.96K
Average payables
9.98K705.86K698.25K803.93K2M
Average inventory
026.29K94.42K567.62K553.25K
Days sales outstanding
002.42K267.65680.84
Days payables outstanding
05.63K06.42K569.53
Days of inventory on hand
021277.963.99K25.58
Receivables turnover
000.151.360.54
Payables turnover
00.0600.060.64
Inventory turnover
01.724.680.0914.27
ROE
0.39-1.8312.5313.081.55
Capex per share
000-0.010

Quarterly Fundamentals Overview

Last date of statement is 2023-08-31 for Q4

Metric History 2022-08-312022-11-302023-02-282023-05-31 2023-08-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
-0.01-0.02-0.02-0.02-0.05
Operating cash flow per share
-0.01-0.01-0.0100
Free cash flow per share
-0.01-0.01-0.0100
Cash per share
00000
Book value per share
-0.02-0.02-0.02-0.02-0.07
Tangible book value per share
-0.02-0.02-0.02-0.03-0.07
Share holders equity per share
-0.02-0.02-0.02-0.02-0.07
Interest debt per share
0.070.060.060.060.06
Market cap
36.98M26.89M29.16M26.02M22.75M
Enterprise value
41.96M32.05M34.66M31.81M28.4M
P/E ratio
-11.16-4.45-3.53-3-1.11
Price to sales ratio
317.66386.18009.21K
POCF ratio
-35.94-45.12-25.81-91.44426.29
PFCF ratio
-36.89-40.61-25.39-91.22445.17
P/B Ratio
-28.84-17.96-14.22-10.84-3.3
PTB ratio
-28.84-17.96-14.22-10.84-3.3
EV to sales
360.47460.270011.49K
Enterprise value over EBITDA
-37.77-30.3-19.01-13.84-12.39
EV to operating cash flow
-40.78-53.78-30.68-111.79532.2
EV to free cash flow
-41.87-48.4-30.19-111.52555.78
Earnings yield
-0.02-0.06-0.07-0.08-0.23
Free cash flow yield
-0.03-0.02-0.04-0.010
Debt to equity
-3.96-3.52-2.76-2.41-0.85
Debt to assets
0.880.90.930.932.84
Net debt to EBITDA
-4.49-4.88-3.02-2.52-2.47
Current ratio
0.180.20.210.210.05
Interest coverage
-6.17-5.37-9.45-10.2-9.75
Income quality
2.060.460.550.13-0.01
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
9.9815.7100317.43
Research and developement to revenue
00000
Intangibles to total assets
0.030.010.010.010.02
Capex to operating cash flow
-0.030.110.020-0.04
Capex to revenue
0.23-0.9500-0.92
Capex to depreciation
-0.56-2.53-0.6-0.02-0.05
Stock based compensation to revenue
4.057.830079.91
Graham number
0.060.070.10.110.29
ROIC
-0.44-0.32-0.52-0.672.68
Return on tangible assets
-0.15-0.26-0.34-0.35-2.54
Graham Net
-0.08-0.07-0.07-0.08-0.09
Working capital
-5.67M-5.81M-6.32M-6.7M-8.38M
Tangible asset value
-1.48M-1.54M-2.09M-2.44M-6.92M
Net current asset value
-5.83M-5.96M-6.46M-6.84M-8.48M
Invested capital
-3.96-3.52-2.76-2.41-0.85
Average receivables
67.96K111.79K114.81K133.14K136.65K
Average payables
-1.89B1.68M1.88M2.12M2.31M
Average inventory
614.33K1.09M1.29M1.51M868.63K
Days sales outstanding
93.88132.05004.9K
Days payables outstanding
2.91K6.05K00142.85
Days of inventory on hand
1.81K4.12K006.42
Receivables turnover
0.960.68000.02
Payables turnover
0.030.01000.63
Inventory turnover
0.050.020014.03
ROE
0.651.011.010.90.75
Capex per share
00000

ALID Frequently Asked Questions

What is Allied Corp. stock symbol ?

Allied Corp. is a CA stock , located in Kelowna of Bc and trading under the symbol ALID

What is Allied Corp. stock quote today ?

Allied Corp. stock price is $0.065 today.

Is Allied Corp. stock public?

Yes, Allied Corp. is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Top Correlated Stocks
Similar Market Cap